Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination

BACKGROUND: Patients with multiple myeloma have unpredictable responses to vaccination for COVID-19. Anti-spike antibody levels can determine which patients develop antibodies at levels similar to healthy controls, and are a known correlate of protection. CASE REPORT: A multiple myeloma patient deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Stampfer, Samuel D., Goldwater, Marissa-Skye, Bujarski, Sean, Regidor, Bernard, Zhang, Wenjuan, Feinstein, Aaron J., Swift, Regina, Eshaghian, Shahrooz, Vail, Eric, Berenson, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654462/
https://www.ncbi.nlm.nih.gov/pubmed/34909634
http://dx.doi.org/10.1016/j.clinpr.2021.100130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654462/
https://www.ncbi.nlm.nih.gov/pubmed/34909634
http://dx.doi.org/10.1016/j.clinpr.2021.100130

Ejemplares similares